On the public citation graph

Artificial Intelligence in Oncology Drug Discovery and Development

0 signed · 325 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1910.04330120050018openalex-snapshot
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
inferredcites →https://doi.org/10.1001/jamainternmed.2016.6008openalex-snapshot
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
inferredcites →https://doi.org/10.1002/0471141755.ph0904s44openalex-snapshot
Overview of High‐Throughput Screening
inferredcites →https://doi.org/10.1002/cpt.1586openalex-snapshot
Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials
inferredcites →https://doi.org/10.1002/cpt.613openalex-snapshot
Therapeutic disasters that hastened safety testing of new drugs
inferredcites →https://doi.org/10.1002/mds.20756openalex-snapshot
CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease
inferredcites →https://doi.org/10.1002/path.4230openalex-snapshot
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
inferredcites →https://doi.org/10.1002/prot.20897openalex-snapshot
On the nature of cavities on protein surfaces: Application to the identification of drug‐binding sites
inferredcites →https://doi.org/10.1002/psp4.2openalex-snapshot
Improving Drug Sensitivity Prediction Using Different Types of Data
inferredcites →https://doi.org/10.1002/sim.7953openalex-snapshot
A Bayesian latent class approach for EHR‐based phenotyping
inferredcites →https://doi.org/10.1007/978-3-030-01171-0_12openalex-snapshot
A Systematic Literature Review on Word Embeddings
inferredcites →https://doi.org/10.1007/978-3-030-31471-2_1openalex-snapshot
Healthcare Perspective
inferredcites →https://doi.org/10.1007/978-3-319-63309-1_7openalex-snapshot
A Review of Image Recognition with Deep Convolutional Neural Network
inferredcites →https://doi.org/10.1007/978-981-10-6808-9_3openalex-snapshot
Introduction to Machine Learning
inferredcites →https://doi.org/10.1007/s15015-013-0268-6openalex-snapshot
International Cancer Genome Consortium
inferredcites →https://doi.org/10.1007/s40264-013-0045-7openalex-snapshot
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries
inferredcites →https://doi.org/10.1007/s40264-013-0132-9openalex-snapshot
Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network
inferredcites →https://doi.org/10.1007/s40264-014-0218-zopenalex-snapshot
Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art
inferredcites →https://doi.org/10.1007/s40264-015-0352-2openalex-snapshot
Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
inferredcites →https://doi.org/10.1007/s40264-017-0558-6openalex-snapshot
Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review
inferredcites →https://doi.org/10.1007/s40264-018-0763-yopenalex-snapshot
Detecting Adverse Drug Events with Rapidly Trained Classification Models
inferredcites →https://doi.org/10.1007/s40264-018-0764-xopenalex-snapshot
Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks
inferredcites →https://doi.org/10.1007/s40290-017-0192-8openalex-snapshot
Integrating Genomics into Drug Discovery and Development: Challenges and Aspirations
inferredcites →https://doi.org/10.1016/0197-2456(89)90015-9openalex-snapshot
Optimal two-stage designs for phase II clinical trials
inferredcites →https://doi.org/10.1016/j.ajhg.2019.02.022openalex-snapshot
Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct
inferredcites →https://doi.org/10.1016/j.breastdis.2013.07.029openalex-snapshot
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
inferredcites →https://doi.org/10.1016/j.canlet.2005.01.041openalex-snapshot
Herceptin: mechanisms of action and resistance
inferredcites →https://doi.org/10.1016/j.ccell.2016.04.014openalex-snapshot
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
inferredcites →https://doi.org/10.1016/j.cell.2010.02.027openalex-snapshot
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
inferredcites →https://doi.org/10.1016/j.cell.2012.04.023openalex-snapshot
The Life History of 21 Breast Cancers
inferredcites →https://doi.org/10.1016/j.cell.2016.08.041openalex-snapshot
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
inferredcites →https://doi.org/10.1016/j.cell.2017.05.038openalex-snapshot
An Expanded View of Complex Traits: From Polygenic to Omnigenic
inferredcites →https://doi.org/10.1016/j.cell.2017.07.029openalex-snapshot
The PI3K Pathway in Human Disease
inferredcites →https://doi.org/10.1016/j.cell.2017.09.002openalex-snapshot
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential
inferredcites →https://doi.org/10.1016/j.cell.2018.03.028openalex-snapshot
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
inferredcites →https://doi.org/10.1016/j.celrep.2013.12.041openalex-snapshot
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
inferredcites →https://doi.org/10.1016/j.ctrv.2018.12.003openalex-snapshot
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
inferredcites →https://doi.org/10.1016/j.drudis.2011.07.006openalex-snapshot
Structure-based drug design to augment hit discovery
inferredcites →https://doi.org/10.1016/j.drudis.2014.03.018openalex-snapshot
An overview of FDA-approved new molecular entities: 1827–2013
inferredcites →https://doi.org/10.1016/j.drudis.2014.10.012openalex-snapshot
Machine-learning approaches in drug discovery: methods and applications
inferredcites →https://doi.org/10.1016/j.ejmech.2009.02.031openalex-snapshot
Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models
inferredcites →https://doi.org/10.1016/j.gde.2009.11.002openalex-snapshot
Targeting the PI3K signaling pathway in cancer
inferredcites →https://doi.org/10.1016/j.ijmedinf.2018.03.013openalex-snapshot
Concurrence of big data analytics and healthcare: A systematic review
inferredcites →https://doi.org/10.1016/j.ijmedinf.2019.05.018openalex-snapshot
Automatic trial eligibility surveillance based on unstructured clinical data
inferredcites →https://doi.org/10.1016/j.jbi.2016.10.007openalex-snapshot
Semi-supervised learning of the electronic health record for phenotype stratification
inferredcites →https://doi.org/10.1016/j.jbi.2017.04.009openalex-snapshot
EHR-based phenotyping: Bulk learning and evaluation
inferredcites →https://doi.org/10.1016/j.jbi.2018.12.004openalex-snapshot
Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platform
inferredcites →https://doi.org/10.1016/j.jbi.2019.103184openalex-snapshot
Comparison of orthogonal NLP methods for clinical phenotyping and assessment of bone scan utilization among prostate cancer patients
inferredcites →https://doi.org/10.1016/j.lungcan.2013.11.023openalex-snapshot
EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancer
inferredcites →https://doi.org/10.1016/j.pmedr.2018.10.008openalex-snapshot
The global burden of multiple chronic conditions: A narrative review
inferredcites →https://doi.org/10.1016/j.sbi.2017.05.004openalex-snapshot
Understanding the GPCR biased signaling through G protein and arrestin complex structures
inferredcites →https://doi.org/10.1016/j.semcancer.2018.01.010openalex-snapshot
Intratumor heterogeneity in epigenetic patterns
inferredcites →https://doi.org/10.1016/j.tcb.2013.11.002openalex-snapshot
EGF receptor trafficking: consequences for signaling and cancer
inferredcites →https://doi.org/10.1016/j.tibtech.2010.02.005openalex-snapshot
High content screening: seeing is believing
inferredcites →https://doi.org/10.1016/j.tig.2012.01.003openalex-snapshot
Evolution of the cancer genome
inferredcites →https://doi.org/10.1016/j.tig.2018.03.005openalex-snapshot
Replicability and Prediction: Lessons and Challenges from GWAS
inferredcites →https://doi.org/10.1016/j.trecan.2018.07.006openalex-snapshot
Balancing the Economics and Ethics of Personalised Oncology
inferredcites →https://doi.org/10.1016/j.yane.2012.02.046openalex-snapshot
Hallmarks of Cancer: The Next Generation
inferredcites →https://doi.org/10.1016/j.ygeno.2017.12.004openalex-snapshot
Identifying pathways affected by cancer mutations
inferredcites →https://doi.org/10.1016/j.ypat.2012.10.013openalex-snapshot
Comprehensive molecular portraits of human breast tumours
inferredcites →https://doi.org/10.1016/s0140-6736(11)60993-8openalex-snapshot
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
inferredcites →https://doi.org/10.1016/s0140-6736(16)31012-1openalex-snapshot
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
inferredcites →https://doi.org/10.1016/s0167-7799(01)01814-5openalex-snapshot
Personalized medicine: revolutionizing drug discovery and patient care
inferredcites →https://doi.org/10.1016/s1386-5056(00)00131-3openalex-snapshot
A computerized method for identifying incidents associated with adverse drug events in outpatients
inferredcites →https://doi.org/10.1016/s1470-2045(13)70442-xopenalex-snapshot
Economic burden of cancer across the European Union: a population-based cost analysis
inferredcites →https://doi.org/10.1016/s1470-2045(14)70228-1openalex-snapshot
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30516-8openalex-snapshot
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
inferredcites →https://doi.org/10.1016/s2213-8587(18)30051-2openalex-snapshot
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
inferredcites →https://doi.org/10.1017/cts.2017.301openalex-snapshot
A survey of practices for the use of electronic health records to support research recruitment
inferredcites →https://doi.org/10.1021/acs.biochem.8b00204openalex-snapshot
Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism
inferredcites →https://doi.org/10.1021/acs.jcim.7b00146openalex-snapshot
Is Multitask Deep Learning Practical for Pharma?
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.6b00248openalex-snapshot
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b00346openalex-snapshot
druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico
inferredcites →https://doi.org/10.1021/acscentsci.6b00367openalex-snapshot
Low Data Drug Discovery with One-Shot Learning
inferredcites →https://doi.org/10.1021/ci500747nopenalex-snapshot
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
inferredcites →https://doi.org/10.1021/pr1007784openalex-snapshot
Nationwide Health Data Management System: A Novel Approach for Integrating Biomarker Measurements with Comprehensive Health Records in Large Populations Studies
inferredcites →https://doi.org/10.1038/35057062openalex-snapshot
Initial sequencing and analysis of the human genome
inferredcites →https://doi.org/10.1038/520609aopenalex-snapshot
Personalized medicine: Time for one-person trials
inferredcites →https://doi.org/10.1038/534314aopenalex-snapshot
Can you teach old drugs new tricks?
inferredcites →https://doi.org/10.1038/bjc.1971.33openalex-snapshot
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
inferredcites →https://doi.org/10.1038/bjc.2014.338openalex-snapshot
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
inferredcites →https://doi.org/10.1038/cddis.2016.150openalex-snapshot
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death
inferredcites →https://doi.org/10.1038/clpt.2011.81openalex-snapshot
Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data
inferredcites →https://doi.org/10.1038/nature10762openalex-snapshot
Clonal evolution in cancer
inferredcites →https://doi.org/10.1038/nature10933openalex-snapshot
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
inferredcites →https://doi.org/10.1038/nature10983openalex-snapshot
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
inferredcites →https://doi.org/10.1038/nature11219openalex-snapshot
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
inferredcites →https://doi.org/10.1038/nature12477openalex-snapshot
Signatures of mutational processes in human cancer
inferredcites →https://doi.org/10.1038/nature13600openalex-snapshot
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
inferredcites →https://doi.org/10.1038/nature13988openalex-snapshot
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
inferredcites →https://doi.org/10.1038/nature15817openalex-snapshot
Pharmacogenomics in the clinic
inferredcites →https://doi.org/10.1038/nature16965openalex-snapshot
Genomic analyses identify molecular subtypes of pancreatic cancer
inferredcites →https://doi.org/10.1038/nature17676openalex-snapshot
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
inferredcites →https://doi.org/10.1038/nbt.1665openalex-snapshot
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
inferredcites →https://doi.org/10.1038/nbt.2287openalex-snapshot
Oncolytic virotherapy
inferredcites →https://doi.org/10.1038/nbt.2877openalex-snapshot
A community effort to assess and improve drug sensitivity prediction algorithms
inferredcites →https://doi.org/10.1038/nbt.3290openalex-snapshot
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
inferredcites →https://doi.org/10.1038/nchembio.1965openalex-snapshot
CRISPR-Cas9–based target validation for p53-reactivating model compounds
inferredcites →https://doi.org/10.1038/nchembio.2007.53openalex-snapshot
Integrating high-content screening and ligand-target prediction to identify mechanism of action
inferredcites →https://doi.org/10.1038/ncomms13615openalex-snapshot
Functional exploration of colorectal cancer genomes using Drosophila
inferredcites →https://doi.org/10.1038/ng.2653openalex-snapshot
The Genotype-Tissue Expression (GTEx) project
inferredcites →https://doi.org/10.1038/ng.2764openalex-snapshot
The Cancer Genome Atlas Pan-Cancer analysis project
inferredcites →https://doi.org/10.1038/ng1768openalex-snapshot
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
inferredcites →https://doi.org/10.1038/nm.3418openalex-snapshot
Self-renewal as a therapeutic target in human colorectal cancer
inferredcites →https://doi.org/10.1038/nm.3841openalex-snapshot
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
inferredcites →https://doi.org/10.1038/nm.3984openalex-snapshot
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
inferredcites →https://doi.org/10.1038/nprot.2014.170openalex-snapshot
Detecting ultralow-frequency mutations by Duplex Sequencing
inferredcites →https://doi.org/10.1038/nrc2013openalex-snapshot
Cancer as an evolutionary and ecological process
inferredcites →https://doi.org/10.1038/nrd.2017.72openalex-snapshot
Bridging the translational innovation gap through good biomarker practice
inferredcites →https://doi.org/10.1038/nrd.2018.168openalex-snapshot
Drug repurposing: progress, challenges and recommendations
inferredcites →https://doi.org/10.1038/nrd2825openalex-snapshot
The microeconomics of personalized medicine: today's challenge and tomorrow's promise
inferredcites →https://doi.org/10.1038/nrg2999openalex-snapshot
Using electronic health records to drive discovery in disease genomics
inferredcites →https://doi.org/10.1038/nrg3723openalex-snapshot
Routes for breaching and protecting genetic privacy
inferredcites →https://doi.org/10.1038/s41389-019-0157-8openalex-snapshot
DeepCC: a novel deep learning-based framework for cancer molecular subtype classification
inferredcites →https://doi.org/10.1038/s41431-018-0177-4openalex-snapshot
Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis
inferredcites →https://doi.org/10.1038/s41431-018-0300-6openalex-snapshot
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records
inferredcites →https://doi.org/10.1038/s41467-018-05044-4openalex-snapshot
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
inferredcites →https://doi.org/10.1038/s41571-019-0283-4openalex-snapshot
What to expect from AI in oncology
inferredcites →https://doi.org/10.1038/s41573-019-0024-5openalex-snapshot
Applications of machine learning in drug discovery and development
inferredcites →https://doi.org/10.1038/s41576-019-0127-1openalex-snapshot
Benefits and limitations of genome-wide association studies
inferredcites →https://doi.org/10.1038/s41584-018-0005-9openalex-snapshot
Biomarkers as drug development tools: discovery, validation, qualification and use
inferredcites →https://doi.org/10.1038/s41586-018-0579-zopenalex-snapshot
The UK Biobank resource with deep phenotyping and genomic data
inferredcites →https://doi.org/10.1038/s41588-018-0183-zopenalex-snapshot
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
inferredcites →https://doi.org/10.1038/s41588-018-0312-8openalex-snapshot
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
inferredcites →https://doi.org/10.1038/s41588-020-0624-3openalex-snapshot
Spatial competition shapes the dynamic mutational landscape of normal esophageal epithelium
inferredcites →https://doi.org/10.1038/s41591-018-0091-xopenalex-snapshot
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
inferredcites →https://doi.org/10.1038/s41592-018-0108-xopenalex-snapshot
Detecting repeated cancer evolution from multi-region tumor sequencing data
inferredcites →https://doi.org/10.1038/s41598-017-13056-1openalex-snapshot
A machine-learning heuristic to improve gene score prediction of polygenic traits
inferredcites →https://doi.org/10.1038/s41598-018-27214-6openalex-snapshot
Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
inferredcites →https://doi.org/10.1038/s41746-019-0081-5openalex-snapshot
Precision medicine and the cursed dimensions
inferredcites →https://doi.org/10.1038/s41746-019-0122-0openalex-snapshot
Deep learning and alternative learning strategies for retrospective real-world clinical data
inferredcites →https://doi.org/10.1038/s41746-019-0148-3openalex-snapshot
Artificial intelligence and machine learning in clinical development: a translational perspective
inferredcites →https://doi.org/10.1038/srep40154openalex-snapshot
An analysis of disease-gene relationship from Medline abstracts by DigSee
inferredcites →https://doi.org/10.1038/tpj.2013.24openalex-snapshot
Pharmacogenomics, ancestry and clinical decision making for global populations
inferredcites →https://doi.org/10.1039/c7sc02664aopenalex-snapshot
MoleculeNet: a benchmark for molecular machine learning
inferredcites →https://doi.org/10.1042/ebc20170029openalex-snapshot
Fragment-based drug discovery and its application to challenging drug targets
inferredcites →https://doi.org/10.1046/j.1532-5415.2002.50607.xopenalex-snapshot
Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA)
inferredcites →https://doi.org/10.1051/bmdcn/2017070315openalex-snapshot
Transglutaminase 2 in human diseases
inferredcites →https://doi.org/10.1056/nejmoa1502309openalex-snapshot
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
inferredcites →https://doi.org/10.1056/nejmra1204892openalex-snapshot
The Implications of Clonal Genome Evolution for Cancer Medicine
inferredcites →https://doi.org/10.1056/nejmra1510062openalex-snapshot
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
inferredcites →https://doi.org/10.1073/pnas.1010978107openalex-snapshot
Accumulation of driver and passenger mutations during tumor progression
inferredcites →https://doi.org/10.1073/pnas.1613365113openalex-snapshot
Deep sequencing of 10,000 human genomes
inferredcites →https://doi.org/10.1074/jbc.m109.097162openalex-snapshot
Redox Regulation of Transglutaminase 2 Activity
inferredcites →https://doi.org/10.1074/jbc.m111.238261openalex-snapshot
Bi-specific Aptamers Mediating Tumor Cell Lysis
inferredcites →https://doi.org/10.1074/jbc.m312990200openalex-snapshot
Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1
inferredcites →https://doi.org/10.1075/nlp.11openalex-snapshot
Biomedical Natural Language Processing
inferredcites →https://doi.org/10.1080/01972243.2017.1354593openalex-snapshot
Weapons of Math Destruction: How Big Data Increases Inequality and Threatens Democracy
inferredcites →https://doi.org/10.1080/15426432.2019.1656815openalex-snapshot
Invisible visits: black middle-class women in the American healthcare system
inferredcites →https://doi.org/10.1080/23288604.2015.1091538openalex-snapshot
Big Data and Health Care: Challenges and Opportunities for Coordinated Policy Development in the EU
inferredcites →https://doi.org/10.1080/23808993.2019.1617632openalex-snapshot
Use of big data in drug development for precision medicine: an update
inferredcites →https://doi.org/10.1089/adt.2015.656openalex-snapshot
Linking Phenotypes and Modes of Action Through High-Content Screen Fingerprints
inferredcites →https://doi.org/10.1089/clinomi.06.05.08openalex-snapshot
UnitedHealthcare to Cover Genetic Testing for Precision Medicine in Depression, Anxiety
inferredcites →https://doi.org/10.1093/annonc/mdl983openalex-snapshot
The rising burden of cancer in the developing world
inferredcites →https://doi.org/10.1093/annonc/mdy457openalex-snapshot
Statistical challenges posed by uncontrolled master protocols: sensitivity analysis of the vemurafenib study
inferredcites →https://doi.org/10.1093/annonc/mdz038openalex-snapshot
On the need to adjust for multiplicity in confirmatory clinical trials with master protocols
inferredcites →https://doi.org/10.1093/annonc/mdz205openalex-snapshot
Optimizing panel-based tumor mutational burden (TMB) measurement
inferredcites →https://doi.org/10.1093/bib/bbx023openalex-snapshot
A review of connectivity map and computational approaches in pharmacogenomics
inferredcites →https://doi.org/10.1093/bib/bby061openalex-snapshot
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases
inferredcites →https://doi.org/10.1093/bioinformatics/bti315openalex-snapshot
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
inferredcites →https://doi.org/10.1093/bioinformatics/btq126openalex-snapshot
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations
inferredcites →https://doi.org/10.1093/bioinformatics/btv076openalex-snapshot
Application of clinical text data for phenome-wide association studies (PheWASs)
inferredcites →https://doi.org/10.1093/bioinformatics/btw207openalex-snapshot
Sparse group factor analysis for biclustering of multiple data sources
inferredcites →https://doi.org/10.1093/bioinformatics/btw765openalex-snapshot
IntegratedMRF: random forest-based framework for integrating prediction from different data types
inferredcites →https://doi.org/10.1093/ije/dyt268openalex-snapshot
Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu
inferredcites →https://doi.org/10.1093/jamia/ocv102openalex-snapshot
A method for systematic discovery of adverse drug events from clinical notes
inferredcites →https://doi.org/10.1093/jamia/ocx111openalex-snapshot
Enabling phenotypic big data with PheNorm
inferredcites →https://doi.org/10.1093/jamia/ocz066openalex-snapshot
High-throughput multimodal automated phenotyping (MAP) with application to PheWAS
inferredcites →https://doi.org/10.1097/00043764-198910000-00001openalex-snapshot
Genetic Alterations During Colorectal-Tumor Development
inferredcites →https://doi.org/10.1097/wnf.0b013e3182285e2dopenalex-snapshot
Safety and Efficacy of Long-Term Disulfiram Aftercare
inferredcites →https://doi.org/10.1101/499392openalex-snapshot
A Modeling Framework for Exploring Sampling and Observation Process Biases in Genome and Phenome-wide Association Studies using Electronic Health Records
inferredcites →https://doi.org/10.1101/685156openalex-snapshot
Analyzing the heterogeneity of rule-based EHR phenotyping algorithms in CALIBER and the UK Biobank
inferredcites →https://doi.org/10.1109/bibm.2013.6732595openalex-snapshot
Mining drug-drug interaction patterns from linked data: A case study for Warfarin, Clopidogrel, and Simvastatin
inferredcites →https://doi.org/10.1109/bibm.2015.7359705openalex-snapshot
Modeling electronic health records in ensembles of semantic spaces for adverse drug event detection
inferredcites →https://doi.org/10.1109/icacci.2017.8126082openalex-snapshot
Deep learning for health informatics: Recent trends and future directions
inferredcites →https://doi.org/10.1109/tcbb.2018.2849968openalex-snapshot
Natural Language Processing for EHR-Based Computational Phenotyping
inferredcites →https://doi.org/10.1109/titb.2011.2165727openalex-snapshot
Data Mining to Generate Adverse Drug Events Detection Rules
inferredcites →https://doi.org/10.1109/tnb.2014.2319158openalex-snapshot
Linking Biochemical Pathways and Networks to Adverse Drug Reactions
inferredcites →https://doi.org/10.1111/1559-8918.2018.01213openalex-snapshot
The Stakes of Uncertainty: Developing and Integrating Machine Learning in Clinical Care
inferredcites →https://doi.org/10.1111/cea.12947openalex-snapshot
Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target
inferredcites →https://doi.org/10.1111/eva.12034openalex-snapshot
Evolutionary foundations for cancer biology
inferredcites →https://doi.org/10.1111/j.1467-9868.2005.00503.xopenalex-snapshot
Regularization and Variable Selection Via the Elastic Net
inferredcites →https://doi.org/10.1111/j.2517-6161.1996.tb02080.xopenalex-snapshot
Regression Shrinkage and Selection Via the Lasso
inferredcites →https://doi.org/10.1111/rssb.12228openalex-snapshot
Random-projection Ensemble Classification
inferredcites →https://doi.org/10.1126/science.1100709openalex-snapshot
Multidimensional Drug Profiling By Automated Microscopy
inferredcites →https://doi.org/10.1126/science.1227670openalex-snapshot
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
inferredcites →https://doi.org/10.1126/science.959840openalex-snapshot
The Clonal Evolution of Tumor Cell Populations
inferredcites →https://doi.org/10.1126/science.aaa6806openalex-snapshot
High burden and pervasive positive selection of somatic mutations in normal human skin
inferredcites →https://doi.org/10.1126/science.aam7344openalex-snapshot
PARP inhibitors: Synthetic lethality in the clinic
inferredcites →https://doi.org/10.1126/science.aau3879openalex-snapshot
Somatic mutant clones colonize the human esophagus with age
inferredcites →https://doi.org/10.1126/scitranslmed.3002774openalex-snapshot
Predicting Adverse Drug Events Using Pharmacological Network Models
inferredcites →https://doi.org/10.1126/scitranslmed.3008604openalex-snapshot
Biobanks and Electronic Medical Records: Enabling Cost-Effective Research
inferredcites →https://doi.org/10.1136/amiajnl-2011-000699openalex-snapshot
Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs
inferredcites →https://doi.org/10.1136/amiajnl-2012-000930openalex-snapshot
Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions
inferredcites →https://doi.org/10.1136/amiajnl-2012-001050openalex-snapshot
Identifying clinical/translational research cohorts: ascertainment via querying an integrated multi-source database
inferredcites →https://doi.org/10.1136/amiajnl-2013-001708openalex-snapshot
Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text
inferredcites →https://doi.org/10.1136/amiajnl-2013-001756openalex-snapshot
Automated identification of drug and food allergies entered using non-standard terminology
inferredcites →https://doi.org/10.1136/jamia.2001.0080254openalex-snapshot
Using Computerized Data to Identify Adverse Drug Events in Outpatients
inferredcites →https://doi.org/10.1136/jamia.2010.008607openalex-snapshot
Drug safety surveillance using de-identified EMR and claims data: issues and challenges
inferredcites →https://doi.org/10.1142/9789811215636_0034openalex-snapshot
Learning a Latent Space of Highly Multidimensional Cancer Data
showing the first 200 of 306 · page through all 306

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/978-981-97-5016-0_7openalex-snapshot
Drug Repurposing in CNS Disorders
inferred← citeshttps://doi.org/10.1007/s11831-023-09936-7openalex-snapshot
A Review of Deep Learning-Based Approaches for Detection and Diagnosis of Diverse Classes of Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-323-89925-3.00001-0openalex-snapshot
An overview of artificial intelligence in drug development
inferred← citeshttps://doi.org/10.1016/b978-0-323-89925-3.00011-3openalex-snapshot
Role of AI in ADME/Tox toward formulation optimization and delivery
inferred← citeshttps://doi.org/10.1016/bs.apha.2025.02.001openalex-snapshot
Harnessing machine learning for rational drug design
inferred← citeshttps://doi.org/10.1016/j.cpet.2021.09.009openalex-snapshot
Artificial Intelligence in Medical Imaging and its Impact on the Rare Disease Community: Threats, Challenges and Opportunities
inferred← citeshttps://doi.org/10.1016/j.nlp.2025.100182openalex-snapshot
Leveraging large language models to predict unplanned ICU readmissions from electronic health records
inferred← citeshttps://doi.org/10.1016/j.oor.2024.100278openalex-snapshot
Theragnostic applications of artificial intelligence (AI) in the field of oral cancer care
inferred← citeshttps://doi.org/10.1016/j.patter.2022.100496openalex-snapshot
Systematic indication extension for drugs using patient stratification insights generated by combinatorial analytics
inferred← citeshttps://doi.org/10.1021/acsomega.5c00549openalex-snapshot
AI-Driven Drug Discovery: A Comprehensive Review
inferred← citeshttps://doi.org/10.1039/d5ra06115fopenalex-snapshot
Polyacrylamide functionalized polysaccharide based nanocomposite semi-interpenetrating polymeric network hydrogel for pH-responsive controlled release of a model neuroprotective drug
inferred← citeshttps://doi.org/10.12688/f1000research.129064.1openalex-snapshot
Progress and challenges for the application of machine learning for neglected tropical diseases
inferred← citeshttps://doi.org/10.12688/f1000research.129064.2openalex-snapshot
Progress and challenges for the application of machine learning for neglected tropical diseases
inferred← citeshttps://doi.org/10.12688/f1000research.129064.3openalex-snapshot
Progress and challenges for the application of machine learning for neglected tropical diseases
inferred← citeshttps://doi.org/10.2174/0113862073265604231106112203openalex-snapshot
Computational Approaches: A New Frontier in Cancer Research
inferred← citeshttps://doi.org/10.22159/ijap.2025v17i6.54181openalex-snapshot
HARNESSING ARTIFICIAL INTELLIGENCE: TRANSFORMING CLINICAL TRIALS FOR THE FUTURE
inferred← citeshttps://doi.org/10.23880/oajpr-16000290openalex-snapshot
Machine Learning Applications in Drug Discovery and Development
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1585180openalex-snapshot
Exploring the ethical issues posed by AI and big data technologies in drug development
inferred← citeshttps://doi.org/10.3390/pharmaceutics16020260openalex-snapshot
Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.